BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 26548601)

  • 21. Long-term results of intraoperative presacral electron boost radiotherapy (IOERT) in combination with total mesorectal excision (TME) and chemoradiation in patients with locally advanced rectal cancer.
    Krempien R; Roeder F; Oertel S; Roebel M; Weitz J; Hensley FW; Timke C; Funk A; Bischof M; Zabel-Du Bois A; Niethammer AG; Eble MJ; Buchler MW; Treiber M; Debus J
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1143-51. PubMed ID: 16979835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immediate radical resection after local excision of rectal cancer: an oncologic compromise?
    Hahnloser D; Wolff BG; Larson DW; Ping J; Nivatvongs S
    Dis Colon Rectum; 2005 Mar; 48(3):429-37. PubMed ID: 15747069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined-modality therapy with sphincter-preserving total mesorectal excision for locally advanced rectal cancer: patient's age and long-term outcome.
    Szynglarewicz B; Matkowski R; Maciejczyk A; Kasprzak P; Forgacz J; Pudelko M
    J Gastrointestin Liver Dis; 2008 Mar; 17(1):49-52. PubMed ID: 18392244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
    Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
    Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?
    Mawdsley S; Glynne-Jones R; Grainger J; Richman P; Makris A; Harrison M; Ashford R; Harrison RA; Osborne M; Livingstone JI; MacDonald P; Mitchell IC; Meyrick-Thomas J; Northover JM; Windsor A; Novell R; Wallace M
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):745-52. PubMed ID: 16199310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rsf-1 expression in rectal cancer: with special emphasis on the independent prognostic value after neoadjuvant chemoradiation.
    Lin CY; Tian YF; Wu LC; Chen LT; Lin LC; Hsing CH; Lee SW; Sheu MJ; Lee HH; Wang YH; Shiue YL; Wu WR; Huang HY; Hsu HP; Li CF; Chen SH
    J Clin Pathol; 2012 Aug; 65(8):687-92. PubMed ID: 22569540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intra-operative radiotherapy of rectal cancer: results of the French multi-institutional randomized study.
    Dubois JB; Bussieres E; Richaud P; Rouanet P; Becouarn Y; Mathoulin-Pélissier S; Saint-Aubert B; Ychou M
    Radiother Oncol; 2011 Mar; 98(3):298-303. PubMed ID: 21339010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are survival rates different for young and older patients with rectal cancer?
    O'Connell JB; Maggard MA; Liu JH; Etzioni DA; Ko CY
    Dis Colon Rectum; 2004 Dec; 47(12):2064-9. PubMed ID: 15657655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term oncologic outcomes of laparoscopic vs open surgery for stages II and III rectal cancer: A retrospective cohort study.
    Zhou ZX; Zhao LY; Lin T; Liu H; Deng HJ; Zhu HL; Yan J; Li GX
    World J Gastroenterol; 2015 May; 21(18):5505-12. PubMed ID: 25987773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
    Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
    Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective approach for upper rectal cancer treatment: total mesorectal excision and preoperative chemoradiation are seldom necessary.
    Marinello FG; Frasson M; Baguena G; Flor-Lorente B; Cervantes A; Roselló S; Espí A; García-Granero E
    Dis Colon Rectum; 2015 Jun; 58(6):556-65. PubMed ID: 25944427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Epidemiological characteristics of elderly dialysed patients aged 75 and more. Study conducted in the Provence-Alpes-Côte d'Azur region of France].
    Delarozière JC; Gentile S; Devictor B; Bongiovanni I; Sambuc R; Robert A; Berland Y;
    Presse Med; 2003 Dec; 32(39):1835-9. PubMed ID: 14713878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of resection of stage IV rectal cancer with mesorectal excision.
    Law WL; Chu KW
    J Surg Oncol; 2006 Jun; 93(7):523-8. PubMed ID: 16705728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience.
    Valentini V; Coco C; Rizzo G; Manno A; Crucitti A; Mattana C; Ratto C; Verbo A; Vecchio FM; Barbaro B; Gambacorta MA; Montoro C; Barba MC; Sofo L; Papa V; Menghi R; D'Ugo DM; Doglietto G
    Surgery; 2009 May; 145(5):486-94. PubMed ID: 19375606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pelvic exenteration for clinical T4 rectal cancer: oncologic outcome in 93 patients at a single institution over a 30-year period.
    Ishiguro S; Akasu T; Fujita S; Yamamoto S; Kusters M; Moriya Y
    Surgery; 2009 Feb; 145(2):189-95. PubMed ID: 19167974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical implication of negative conversion of predicted circumferential resection margin status after preoperative chemoradiotherapy for locally advanced rectal cancer.
    Lee NK; Kim CY; Park YJ; Yang DS; Yoon WS; Kim SH; Kim J
    Eur J Radiol; 2014 Feb; 83(2):245-9. PubMed ID: 24268789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
    Shanmugan S; Arrangoiz R; Nitzkorski JR; Yu JQ; Li T; Cooper H; Konski A; Farma JM; Sigurdson ER
    Ann Surg Oncol; 2012 Jul; 19(7):2178-85. PubMed ID: 22395978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early discontinuation but not the timing of adjuvant therapy affects survival of patients with high-risk colorectal cancer: a population-based study.
    Ahmed S; Ahmad I; Zhu T; Arnold FP; Faiz Anan G; Sami A; Yadav SK; Alvi R; Haider K
    Dis Colon Rectum; 2010 Oct; 53(10):1432-8. PubMed ID: 20847626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative chemoradiation followed by transanal excision for rectal cancer.
    Huh JW; Jung EJ; Park YA; Lee KY; Sohn SK
    J Surg Res; 2008 Aug; 148(2):244-50. PubMed ID: 17936793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.